Bloomberg's Wilson on Winners, Losers, Stock of the Day (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. Guest: Bloomberg stocks editor David Wilson on today's market winners, losers, and Stock of the Day: Belmond (BEL).See omnystudio.com/listener for privacy information.
12 Jul 201612min
RBC's Golub Favors US Equities In Low Vol Environment (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Jonathan Golub, Chief US Market Strategist for RBC Capital Markets, on the markets, earnings, and why the call for lower returns on equity is too early.See omnystudio.com/listener for privacy information.
12 Jul 201611min
Conference Board's Maselli on European Labor Markets (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Ilaria Maselli, Senior Economist, Europe, at the Conference Board, on the labor markets and future of employment of Europe.See omnystudio.com/listener for privacy information.
12 Jul 201611min
Bloomberg's Larson: Why Tech Companies Get Sued in China(Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. Guest: Matt Larson, Litigation Analyst for Bloomberg Intelligence, on why tech companies are getting sued in China.See omnystudio.com/listener for privacy information.
12 Jul 20168min
John Sculley Sees $10 Billion in Revenues for RxAdvance (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Former Apple and Pepsi CEO John Sculley on his current entrepreneurial endeavors in healthcare, and the strategies outlined in his new book "Moonshot!: Game-Changing Strategies to Build Billion-Dollar Businesses."See omnystudio.com/listener for privacy information.
12 Jul 201611min
Pemberton's Durcikova: Investing in Toronto Real Estate (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Mariana Durcikova, Broker at Pemberton Group, on the benefits to investing in Toronto real estate, compared to NYC.See omnystudio.com/listener for privacy information.
12 Jul 201611min
Shire's Ornskov on $1 Billion Potential for Dry-Eye Drug(Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Shire CEO Flemming Ornskov on the outlook for the company after getting FDA approval for Xiidra drops to treat dry-eye disease.See omnystudio.com/listener for privacy information.
12 Jul 20168min
Gong.io's Bendov on Pioneering Intelligence Sales Tool (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Amit Bendov, CEO and Co-Founder Gong.io, will discuss his new sales intelligence tool, the evolution of artificial intelligence, and how different industries are using it.See omnystudio.com/listener for privacy information.
12 Jul 20168min
